Preparation of Ca-Alginate Microparticles and Its Application for Phenylketonuria Oral Therapy
- 28 February 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in Industrial & Engineering Chemistry Research
- Vol. 50 (7) , 4106-4112
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuriaProceedings of the National Academy of Sciences, 2008
- Development of Pegylated Forms of Recombinant Rhodosporidium toruloides Phenylalanine Ammonia-Lyase for the Treatment of Classical PhenylketonuriaMolecular Therapy, 2005
- How practical are recommendations for dietary control in phenylketonuria?The Lancet, 2002
- STUDY ON A NOVEL STRATEGY TO TREATMENT OF PHENYLKETONURIAArtificial Cells, Blood Substitutes, and Biotechnology, 2002
- SHORT REPORT: PKU adults and their return to diet: Predicting diet continuation and maintenanceJournal of Inherited Metabolic Disease, 2001
- A different approach to treatment of phenylketonuria: Phenylalanine degradation with recombinant phenylalanine ammonia lyaseProceedings of the National Academy of Sciences, 1999
- Protein release from alginate matricesAdvanced Drug Delivery Reviews, 1998
- A new amino acid mixture permits new approaches to the treatment of phenylketonuriaActa Paediatrica, 1994
- Nano- and microparticles for the delivery of polypeptides and proteinsAdvanced Drug Delivery Reviews, 1993
- The metabolism of cinnamic acid by healthy and phenylketonuric adults: A kinetic studyJournal of Mass Spectrometry, 1984